Grace Therapeutics (GRCE) Operating Margin (2020 - 2021)
Grace Therapeutics' (GRCE) quarterly Operating Margin came in at 2000.0% in Q1 2021, up 17.52% quarter-over-quarter from 2424.69% in Q4 2020.
Powered by 
Analysis
Grace Therapeutics (GRCE) Operating Margin (2020 - 2021) Analysis & Trends
Grace Therapeutics has disclosed Operating Margin across 2 years of filings, most recently posting 2000.0% for Q1 2021.
- In Q1 2021, Operating Margin changed N/A year-over-year to 2000.0%; the TTM figure through Mar 2022 stood at 7953.57% (changed N/A YoY), while the FY2021 annual figure was 8377.04%, changed N/A from the prior year.
- Operating Margin came in at 2000.0% for Q1 2021 at Grace Therapeutics, up from 2424.69% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 2000.0% in Q1 2021 to a low of 2424.69% in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 28.21% |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 37.86% |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | -3.52% |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 32.97% |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 28.37% |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 9.03% |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | - |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 41.69% |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 42.23% |
| 10 | Grace Therapeutics | 39.38 Mn | 39.38 Mn | - | - |